Analysis: Cboe, Citadel Securities backed group sues CFTC over stock perpetuals

The Capital Markets Alliance (CMA), backed by Cboe and Citadel Securities, sued the CFTC to halt perpetual futures trading on individual US stocks, arguing they should be classified as security-based swaps. The CFTC approved the contracts, but the CMA claims they should require SEC registration for retail sales. The lawsuit also questions the CFTC's approval process, which automatically approved the products after 45 days without objection.

Original reporting
Published Nov 4, 2026, 1:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 2:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Analysis: Cboe, Citadel Securities backed group sues CFTC over stock perpetuals — source image
Decision brief

The 30-second read

$CBOEBearishLow
01

Why it matters

The case could set a precedent for how equity perpetuals are regulated, affecting exchanges, brokers, and retail investors.

02

Market read

Regulatory uncertainty around a new class of derivatives may limit market expansion and affect pricing of related products.

03

What to watch

Potential for alternative venues (e.g., crypto exchanges) to fill the gap if equity perps are blocked.

Relevance 7/10Novelty 6/10Timing: today

Background

A newly formed trade body, the Capital Markets Alliance, filed a lawsuit in New York seeking to overturn CFTC approval of stock perpetual futures, arguing they are security-based swaps.

Company-level read

Ticker impact

$CBOEBearishMedium confidence
Context

Cboe is a named defendant in the lawsuit challenging CFTC approval of stock perpetual futures, making the regulatory outcome directly relevant to its business.

Expected impact

likely pressure as the market prices in regulatory uncertainty for Cboe's futures business

Evidence & confidence

The lawsuit seeks to block CFTC approvals; if successful, Cboe may lose a new revenue stream.

Market effects

May dampen broader market interest in equity perpetual products across exchanges.

U.S. futures markets could see reduced innovation activity.

Regulatory outcome could influence how other jurisdictions treat similar products.

Counterpoint

If the court dismisses the suit, Cboe could gain a first-mover advantage in a new product class.

Key entities

  • Capital Markets Alliance

    Trade body suing the CFTC over stock perpetual futures.

  • CFTC

    U.S. Commodity Futures Trading Commission that approved the perpetual futures.

Related articles

$CBOEMed

Cboe and Citadel Securities-backed industry body contests CFTC green light for single-stock perpetual derivatives

The Capital Markets Alliance (CMA), backed by Cboe and Citadel Securities, sued the CFTC over its approval of single-stock perpetual derivatives. The CMA argues these products should fall under SEC jurisdiction and that the CFTC violated the Administrative Procedure Act. The CMA seeks to vacate the approvals, but a judge denied an emergency restraining order, indicating the CMA may succeed in its claim. The CFTC and CMA are set to respond by November 6 and 10, respectively.

$CBOEMed

Cboe and Citadel Securities Are Suing to Overturn the CFTC’s Approval of Stock Perpetual Futures. Could That Slow Hyperliquid?

Cboe Global Markets (CBOE) and Citadel Securities sued to overturn the CFTC's approval of stock perpetual futures, which Hyperliquid (HYPE) lists outside the U.S. The lawsuit aims to classify these contracts as security-based swaps and halt trading. HYPE's token is trading at $86, down 1.3% in 24 hours but up 7.4% in a week. The lawsuit could impact U.S. exchanges like Coinbase (COIN) and Bitnomial, while Hyperliquid's offshore operations may face fewer competitors in the short term.

$CBOEMed

CFTC Perpetual Futures on Stocks Hit by Cboe-Backed Lawsuit

CFTC approved perpetual futures tied to individual stocks for trading on US exchanges. Chairman Michael Selig stated the contracts are approved under Commission Regulation 40.3. The Capital Markets Alliance, including Cboe, Citadel Securities, and others, filed a lawsuit challenging the approval, arguing the contracts fall under SEC jurisdiction and alleging procedural violations. Cboe's CEO Craig Donohue stated the approvals threaten investor protection and market integrity.

$CBOEMed

Cboe and Citadel Sue to Stop US Stock Perps Hours After the CFTC Approved Them: Why Hyperliquid’s $5 Billion-a-Day Market Has the Most at Stake

Cboe and Citadel Securities sued the CFTC to block stock perpetual futures, hours after the regulator approved them. The lawsuit aims to prevent US exchanges from offering these products, which are popular on Hyperliquid's platform. Hyperliquid's HYPE token saw volatility but remains up 2.8% in 24 hours. The outcome could impact Hyperliquid's US market expansion and competitors like Coinbase and Kalshi.

$CBOEMed

Cboe Joins CMA Lawsuit Seeking to Overturn CFTC Stock Perpetual Approval

Cboe joined the Capital Markets Alliance (CMA) in suing to overturn the CFTC's approval of single-stock perpetual contracts. The case seeks to classify these derivatives as security-based swaps and block the approval. The CFTC allowed trading to begin on Nov. 3, while Cboe's CEO argues they should be regulated under U.S. securities laws. The case involves Coinbase, Kalshi, and Bitnomial.